With a focus on 30,688 people treated for HIV between 2003 and 2017 in seven Latin American countries, the study, published in The Lancet HIV, finds dramatic increases in life expectancy.
People living with human immunodeficiency virus (HIV) and without known cardiovascular disease have two to three times the noncalcified coronary plaque burden of non-HIV healthy volunteers, according to a new Canadian study. Researchers said the results underscore the importance of a heart-healthy lifestyle in people living with HIV.
A new test that measures the quantity and quality of inactive HIV viruses in the genes of people living with HIV may eventually give researchers a better idea of what drugs work best at curing the disease.
What The Study Did: The results of incorporating HIV screening into COVID-19 testing at an emergency department in Chicago are reported in this study.
The COVID-19 pandemic is affecting people with or at risk for HIV by interfering with HIV treatment and prevention services, and by threatening individual health. An effective response to these dual pandemics requires collaboration to accelerate basic and clinical research, and implementation science to introduce evidence-based strategies into real-world settings. This message comes from a review article co-authored by NIAID director Anthony S. Fauci, M.D., and colleagues published in the Journal of Infectious Diseases.
Eliminating racist and anti-LGBTQ policies is essential to improving the health of Black gay, bisexual and other sexual minority men, according to a Rutgers-led research team. The study, published in the American Journal of Preventive Medicine, examined the impact that U.S. state-level structural racism and anti-LGBTQ policies have on the psychological and behavioral health of Black and white sexual minority men.
New CDC data show that people with HIV who experienced IPV in the past 12 months were more likely to engage in behaviors associated with elevated HIV transmission risk, were less likely to be engaged in routine HIV care and more likely to seek emergency care services and have poor HIV clinical outcomes. The findings are reported in the American Journal of Preventive Medicine, published by Elsevier.
A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule.
A review of more than 10,000 medical records in urban Malawi, South Africa, Uganda and Zimbabwe has yielded important insight about pregnancy and neonatal outcomes in these communities as well as the frequency with which different complications occur. The data provide researchers conducting the DELIVER study a frame of reference for assessing the safety of daily PrEP and the monthly dapivirine ring in pregnant women but should be of value to local authorities as well.
A team led by scientists at the UNC School of Medicine discovered an important vulnerability of the AIDS-causing retrovirus HIV, and has shown in preclinical experiments that a widely used diabetes drug, metformin, seems able to exploit this vulnerability.